Mumbai, Oct. 1 -- Lupin announced the launch of Rivaroxaban for Oral Suspension, 1 mg/mL, in the United States. Rivaroxaban for Oral Suspension, 1 mg/mL is bioequivalent to Xarelto(R) for Oral Suspension, 1 mg/mL of Janssen Pharmaceuticals, Inc.

Published by HT Digital Content Services with permission from Capital Market....